AesMed Co., Ltd. is a cosmetics and medical device manufacturer and sales company specializing in hair loss treatment. For the past 23 years, we have been at the forefront of the domestic and international hair loss markets. We provide products to 7 university hospitals, 500 hospitals, clinics, and major hair transplant centers, and so far, 5 million procedures have been performed with AesMed’s AGF39. The cytokine therapy for alopecia with AGF39 is now recognized as the standard mesotherapy solution for alopecia treatment.

In addition, the research results were introduced and published in the SCI Journal and the World Congress for Hair Research. (SCI Journal, Journal of Dermatology 2012:39:1-2 / World Congress for hair research 2013, Edinburgh, Scotland p056. / World Congress for Hair Research 2014, Jeju, Korea p180.) AGF39 is getting widely noted to the world by academic exchanges in the medical alopecia field as an essential method for treatment.